The Effect of Processed Tomato Products on CVD Risks (TOMATO)
This study has been completed.
Sponsor:
Penn State University
Collaborator:
Tomato Products Wellness Council
Information provided by:
Penn State University
ClinicalTrials.gov Identifier:
NCT00937742
First received: July 10, 2009
Last updated: NA
Last verified: July 2009
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The primary working hypothesis is that consuming processed tomatoes frequently/daily will favorably improve endothelium and platelet function disease-risk biomarker profiles in adult men and women compared to consuming no or relatively low amounts of processed tomatoes.
| Condition | Intervention |
|---|---|
|
Cardiovascular Disease |
Dietary Supplement: Tomato products |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | The Effect of Processed Tomatoes on Endothelium- and Platelet- Function |
Resource links provided by NLM:
MedlinePlus related topics:
Diabetes Medicines
Drug Information available for:
Solanum lycopersicum
U.S. FDA Resources
Further study details as provided by Penn State University:
Primary Outcome Measures:
- Platelet and monocyte function/activity [ Time Frame: Baseline and end of intervention phase (week 6) ] [ Designated as safety issue: No ]
- Vascular function [ Time Frame: Baseline and end of intervention phase (week 6) ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Lipids [ Time Frame: Baseline and end of intervention phase (week 6) ] [ Designated as safety issue: No ]
- Insulin/Glucose [ Time Frame: Baseline and end of intervention phase (week 6) ] [ Designated as safety issue: No ]
- Inflammatory Markers [ Time Frame: Baseline and end of intervention phase (week 6) ] [ Designated as safety issue: No ]
| Enrollment: | 32 |
| Study Start Date: | January 2008 |
| Study Completion Date: | April 2009 |
| Primary Completion Date: | September 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Non-tomato products
Non-tomato products (i.e. teriyaki marinade, sprite, applesauce) to be consumed daily in replace of tomato products
|
Dietary Supplement: Tomato products
Specified amounts of tomato products (i.e. tomato juice, ketchup, salsa, tomato soup, spaghetti sauce) to be consumed daily during a 6 week intervention phase.
|
Eligibility| Ages Eligible for Study: | 21 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
men and women (>21 <70 years) nonsmokers, with a body mass index (BMI) ranging of 25 to 35 kg/m2, BP < or = 140/90 mmHg
Exclusion Criteria:
- Total cholesterol (TC) is greater than 300 mg/dL;
- Fasting triglyceride is greater than 300 mg/dL;
- LDL cholesterol (LDL-C) is greater than 180 mg/dL;
- Female subjects who are pregnant or lactating;
- Subjects who are actively losing weight or trying to lose weight;
- Subjects with known allergy or intolerance to tomato products;
- taking any medications that would interfere with outcomes of the study, ie. lipid lowering medications, anti-inflammatory drugs, dietary supplements, such as fish oil or evening primrose;
- subjects' with documented atherosclerotic disease, inflammatory disease, diabetes mellitus, uncontrolled hypertension (>=140/90 mm Hg - ok if controlled below this limit with medication), or other systemic diseases;
- subjects with low hematological counts as determined by >or <15% the upper or lower cut-off values of normal established for the lab;
- Smokers. -
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00937742
Locations
| United States, Pennsylvania | |
| Penn State University | |
| University Park, Pennsylvania, United States, 16802 | |
Sponsors and Collaborators
Penn State University
Tomato Products Wellness Council
Investigators
| Principal Investigator: | Penny M Kris-Etherton, PhD | Penn State University |
More Information
No publications provided
| Responsible Party: | Penn State University, Penny Kris-Etherton |
| ClinicalTrials.gov Identifier: | NCT00937742 History of Changes |
| Other Study ID Numbers: | PKE TOMATO |
| Study First Received: | July 10, 2009 |
| Last Updated: | July 10, 2009 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Penn State University:
|
cardiovascular disease Lycopene Tomato |
Additional relevant MeSH terms:
|
Cardiovascular Diseases |
ClinicalTrials.gov processed this record on May 16, 2013